All
Top 5 Cancer Vaccine Stories from 2024
With breakthroughs from melanoma to pancreatic cancer, this has been a year of great promise in the field of cancer vaccines.
The Power of Voice in MPN Management
A health care professional talks about the importance of a supportive care team, especially since every patient with MPNs presents differently.
Jace Yawnick of Jace Beats Cancer on the ‘Roller Coaster’ of Life in Remission
After sharing his cancer story online, Jace Yawnick is in a state of technical remission after receiving a diagnosis of non-Hodgkin lymphoma at age 25.
Cancer Memories of a Christmas Past
This Christmas, my wish for all of you is that you read this and feel seen, that someone out there knows how very hard this is for you.
Top 4 Stories From the 2024 ASH Annual Meeting
CURE® highlights some top stories from the ASH Annual Meeting, focusing on B-cell acute lymphoblastic leukemia, multiple myeloma and other blood cancers.
Real-World Data May Confirm Monjuvi’s Efficacy in Large B-Cell Lymphoma
The real-world effectiveness of Monjuvi for relapsed or refractory diffuse large B-cell lymphoma in the U.S. was demonstrated, according to data from a retrospective analysis.
FDA Grants Breakthrough Therapy Designation to Trodelvy for Small Cell Lung Cancer
The FDA has granted breakthrough therapy designation Trodelvy for adults with extensive-stage small cell lung cancer who progressed on/after chemotherapy.
Ways to Organize Medical Bills During Cancer
Utilizing tools such as spreadsheet trackers can make a big difference when organizing cancer-related medical bills and noting out-of-pocket maximums.
A Christmas Carol: Lessons Learned From the Past, Present and Future
Watching "Scrooge" every Christmas made me reflect on my own journey, where my past struggles with illness taught me valuable lessons about forgiveness, love and joy.
Top FDA Approvals of Oncology Therapies in 2024
As we near the end of 2024, CURE is looking back at the top FDA approval stories of the year.
Epkinly Leads to Responses in Heavily Pretreated Patients With CLL
Among patients with heavily pretreated chronic lymphocytic leukemia, treatment with Epkinly monotherapy showed deep responses.
Recognizing Excellence in Oncology Nursing
An oncology nurse demonstrated care not only to her patients with cancer but also to her own staff.
FDA Grants Jemperli Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer
Jemperli received breakthrough therapy designation by the FDA for locally advanced mismatch repair deficient/microsatellite instability-high rectal cancer.
Darzalex Regimen May Improve MRD Responses in Multiple Myeloma
Patients newly diagnosed with multiple myeloma who are transplant ineligible or deferred may benefit from receiving a Darzalex treatment combination.
How to Self Advocate When Insurance Says No to Cancer Treatment Coverage
When insurance denies coverage of cancer treatment, patients with cancer don’t need to take no for an answer, an expert explained.
FDA Approves Braftovi Plus Erbitux and Chemo for Metastatic Colorectal Cancer Subset
Braftovi received accelerated approval with Erbitux and mFOLFOX6 for metastatic colorectal cancer with a BRAF V600E mutation.
Reflecting on Cancer During a Christmas Morning Run
A reflective Christmas morning run, following a cancer diagnosis, inspires profound gratitude for life and a renewed commitment to living a meaningful life.
NFL Star Randy Moss Undergoing Cancer Treatment, Montell Jordan Shares Update and More
From a Pro Football Hall of Famer announcing his diagnosis to an R&B star’s latest update, here’s what’s happening in the cancer space this week.
Zejula-Jemperli Combo Shows Promising Responses in Breast Cancer Subset
A combination of presurgical Zejula and Jemperli showed promising treatment responses in certain patients with ER-positive, HER2-negative breast cancer.
Enhertu May Help Preserve Quality of Life in HER2-Positive Breast Cancer
Treatment with Enhertu showed favorable outcomes regarding health-related quality of life in patients with HER2-positive breast cancer, regardless of brain metastases.
Targeting Multiple Pathways Improves Outcomes in Some With Metastatic Breast Cancer
Targeting the estrogen receptor and HER2 pathways improved progression-free survival in patients with HR-positive, HER2-positive metastatic breast cancer.
Embracing Gratitude During the Holidays
A survivor shares tips on ways to practice gratitude the holiday season.
UGN-102 May Improve Quality of Life Versus Surgery in Bladder Cancer
Treatment with UGN-102 has shown promise as a non-surgical alternative when compared with a surgical approach for certain patients with bladder cancer.
What is Follicular Lymphoma and Why Are Better Treatments Needed?
CURE® spoke with an expert about follicular lymphoma, a disease that is still considered incurable.
Ryoncil Receives FDA Approval for Children With GVHD
This marks the first mesenchymal stromal cell therapy approved by the FDA for children with acute graft versus host disease.
FDA Approves Ensacove for ALK-Positive NSCLC
The Food and Drug Administration has approved Ensacove for patients with ALK-positive locally advanced or metastatic non-small cell lung cancer who have not previously received an ALK-inhibitor.
How to Get the Most from Patient Portals During a Cancer Journey
An expert advises a few things to keep in mind when patients with cancer are navigating these platforms.
A Holiday Poem: Who Says Cancer Doesn’t Rhyme?
The holiday season is here, so here’s a festive poem to remind us that cancer should not control us during this time.
Understanding Prostate Cancer Treatment Side Effects Is Key
A study showed that patients with prostate cancer should consider the long-term side effects of treatments before deciding on the appropriate options.
Imbruvica-Venetoclax Shows Promise in Managing CLL
A combination of Imbruvica and venetoclax showed significantly prolonged progression-free survival in patients with untreated CLL, an expert explained.
